Yhn ScienceBiology first seen 1 h ago, last 28 min ago, peak #12
Drugmakers say GLP-1 weight-loss drugs may slow biological aging
Original: Weight-loss drugs show signs of slowing biological aging, say drugmakers
Eli Lilly and Novo Nordisk report that their GLP-1 weight-loss drugs show signs of slowing biological aging, based on measurements from aging clocks. The claim, highlighted by MIT Technology Review, suggests the medications may do more than drive weight loss, potentially affecting aging processes themselves. The announcement is drawing attention because it positions widely used obesity drugs as possible anti-aging therapies, though independent verification of the aging-clock findings remains an open question.
Why now: GLP-1 drugs are already hugely popular, and claims they could slow aging dramatically expand their perceived significance.
Eli LillyNovo NordiskMIT Technology Review
Rank over time, top of the chart is #1. 2 snapshots from 1 h ago to 28 min ago.
Evidence
Elsewhere
API: https://socialmediatrends-api.osmike.com/v1/trends/1279946